Uncovering Institutional Buying In Allogene Therapeutics Inc (NASDAQ: ALLO)
Currently, there are 208.78M common shares owned by the public and among those 136.69M shares have been available to trade. The company’s stock has a 5-day price change of 52.17% and -1.41% over the past three months. ALLO shares are trading 9.03% year to date (YTD), with the 12-month market performance down to -29.44% lower. […]
Allogene Therapeutics Inc (NASDAQ: ALLO) Stock In Prove Me State
Allogene Therapeutics Inc (ALLO) concluded trading on Thursday at a closing price of $2.68, with 3.17 million shares of worth about $8.51 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -12.13% during that period and on July 11, 2024 the price saw a […]
Set Your Sights On Allogene Therapeutics Inc (NASDAQ: ALLO)’S Upside Potential
Allogene Therapeutics Inc (ALLO) concluded trading on Wednesday at a closing price of $2.15, with 1.78 million shares of worth about $3.82 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -40.61% during that period and on Wednesday the price saw a loss of […]
Allogene Therapeutics Inc (NASDAQ: ALLO): Hunting Genuine Value In Market Debris
Currently, there are 208.78M common shares owned by the public and among those 136.69M shares have been available to trade. The company’s stock has a 5-day price change of 4.35% and -44.06% over the past three months. ALLO shares are trading -25.23% year to date (YTD), with the 12-month market performance down to -49.47% lower. […]
Allogene Therapeutics Inc (ALLO) Outlook Starting To Look Brighter?
Allogene Therapeutics Inc (ALLO) concluded trading on Thursday at a closing price of $2.44, with 5.88 million shares of worth about $14.35 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -16.15% during that period and on June 20, 2024 the price saw a […]
Is There More Upside Ahead For Allogene Therapeutics Inc (NASDAQ: ALLO)
Allogene Therapeutics Inc (ALLO) concluded trading on Wednesday at a closing price of $4.15, with 4.08 million shares of worth about $16.92 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -6.95% during that period and on Wednesday February 7 the price saw a […]
Analyst Expect Big Moves From Allogene Therapeutics Inc (NASDAQ: ALLO)
Fidelity Management & Research Co recently announced the acquisition of new stake in Allogene Therapeutics Inc (NASDAQ:ALLO). The institutional investor has increased its shareholding in the Healthcare company by 0.91% to 25.14 million shares with purchase of 0.23 million shares. This fresh investment now brings its stake to 14.94% valued currently at $59.09 million. In […]
Institutional Exposure To Allogene Therapeutics Inc (ALLO)
Fidelity Management & Research Co has recently announced that it has increased stake in Allogene Therapeutics Inc (NASDAQ:ALLO) by 0.91%. After grabbing 25.14 million shares, the institutional investor is now in possession of 0.23 million shares of the Healthcare Company. The new investment brought the stake of investor firm to 14.94% having worth around $59.09 […]
Allogene Therapeutics Inc (NASDAQ: ALLO): Hunting Genuine Value In Market Debris
Fidelity Management & Research Co recently announced the acquisition of new stake in Allogene Therapeutics Inc (NASDAQ:ALLO). The institutional investor has increased its shareholding in the Healthcare company by 0.91% to 25.14 million shares with purchase of 0.23 million shares. This fresh investment now brings its stake to 14.94% valued currently at $59.09 million. In […]
Investors Should Take Note Of Allogene Therapeutics Inc (ALLO)
Fidelity Management & Research Co has recently announced that it has increased stake in Allogene Therapeutics Inc (NASDAQ:ALLO) by 0.91%. After grabbing 25.14 million shares, the institutional investor is now in possession of 0.23 million shares of the Healthcare Company. The new investment brought the stake of investor firm to 15.00% having worth around $70.91 […]
